#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Rhabdomyosarcoma Splenic marginal zone lymphoma Acquired C1 inhibitor deficiency Neoplasm malignant CDKL5 deficiency disorder Tuberous sclerosis complex Oesophageal adenocarcinoma Kidney transplant rejection Osteogenesis imperfecta Castleman's disease Glomerulonephritis membranoproliferative Infertility female Carcinoid tumour Krabbe's disease More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Treatment Sarcoidosis – Life with Disease Cerebral arteriovenous malformation haemorrhagic Activated PI3 kinase delta syndrome – Treatment Bronchiolitis obliterans syndrome – Treatment Leiomyosarcoma recurrent Pituitary-dependent Cushing’s syndrome – Diagnostics Primary mediastinal large B-cell lymphoma – Treatment Urea cycle disorder – Diagnostics Uterine leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SAR443820 Lbl-007 Travoprost Selexipag Gad20-209-Fsp-A4 Levodropropizine Sibeprenlimab Mps-106 Escitalopram Oxalate NORETHISTERONE ACETATE STREPTOCOCCUS PYOGENES Nicotinamide Mk-0482 Rifamycin Sodium ZALFERMIN Fluorescein Sodium Entecavir POTASSIUM CLAVULANATE Asciminib Hydrochloride Triglycerides, Medium Chain More therapies…

    Learn about Your Condition

    Obesity Autoimmune disorder Rhabdomyosarcoma Rectosigmoid cancer Hypoalbuminaemia Sarcoidosis Familial hypertriglyceridaemia Small intestine adenocarcinoma Rasmussen encephalitis Ovarian cancer metastatic Diarrhoea Eye pain Staphylococcal bacteraemia VEXAS syndrome Spinal pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Medical Center Berbatov Ltd.

Medical Center Berbatov Ltd.

Ulitsa Beli Drin 9, Yambol, 8600, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • KAI-9531 in Adults With Obesity or Overweight and Diabetes

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • HRS 9531
    Bulgaria Czechia Germany Hungary Poland Spain

  • A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

  • A study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Spain

  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Investigated Drugs:
    • Ziltivekimab
    Belgium Bulgaria Croatia Czechia Denmark Germany +12

  • Study on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight

    Not recruiting

    3 1
    Investigated Drugs:
    • Maridebart Cafraglutide
    Bulgaria Czechia Germany Hungary Italy Poland

  • Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Belgium Bulgaria Denmark Finland France Germany +4

  • Study on the Effects of Switching from Daily Basal Insulin to Weekly Insulin Icodec Compared to Daily Insulin Glargine in Adults with Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Glargine
    • Insulin Icodec
    Bulgaria Germany Poland Spain

  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Gliclazide
    • Metformin
    • Dapagliflozin
    Bulgaria Hungary Latvia Lithuania Poland
Previous Page
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!